Objectives: Intraperitoneal (IP) injection of 3.5 g/kg L-arginine (known to induce acute pancreatitis) in rats will result in much greater increases in serum ornithine versus citrulline concentration (Crit Care Med. 2008; 36:2117Y2127). These data indicate a major role of arginase in the catabolism of L-arginine. Therefore, we tested the effects of the irreversible arginase inhibitor (+)-S-2-amino-6-iodoacetamidohexanoic acid (AIHA) on L-arginineYinduced acute pancreatitis.
L
arge doses (2.5Y5 g/kg) of intraperitoneally (IP) injected L-arginine are known to induce acute necrotizing pancreatitis in rats and mice. 1Y4 The pathomechanism of L-arginine pancreatitis is unknown, especially concerning the early events leading to the disease.
Two key enzymes that are involved in the metabolism of L-arginine are nitric oxide synthase (NOS) and arginase ( F1 Fig. 1 ). 5 Nitric oxide synthase has 3 isoforms: the constitutive endothelial (eNOS) and neuronal (nNOS) and an inducible form (iNOS). They catalyze the conversion of L-arginine to nitric oxide and L-citrulline. Arginase, which has 2 isoforms (types I and II), hydrolyzes L-arginine to L-ornithine and urea. These 2 arginase isoforms are encoded by 2 different genes and differ in molecular properties, tissue distribution, subcellular location, and regulation of expression. Arginase I is localized in the cytosol and is highly expressed in the liver and to a much less extent in a few other tissues. Arginase II is a mitochondrial enzyme, which is widely distributed in extrahepatic tissues.
In arginine-induced pancreatitis, pancreatic constitutive NOS activity was depleted at 6 hours then gradually increased to significantly higher level than the control at 24 hours. 6 The activity of pancreatic iNOS was significantly increased at 24 hours after L-arginine injection.
Most of the IP injected L-arginine is converted to Lornithine rather than L-citrulline, 7, 8 therefore indicating a major role of arginase in the catabolism of this basic amino acid. Furthermore, we have recently shown that administration of Lornithine induces a more severe pancreatitis compared with Larginine. 7 Therefore, we speculated that L-arginine produces a toxic effect on the pancreas, at least in part, via L-ornithine. The aim of this study was to test the effects of the irreversible arginase inhibitor (+)-S-2-amino-6-iodoacetamidohexanoic acid (AIHA) on L-arginineYinduced acute pancreatitis.
MATERIALS AND METHODS

Materials
(+)-S-2-amino-6-iodoacetamidohexanoic acid was purchased from Alexis Biochemicals
AQ1
. All other chemicals were obtained from Sigma-Aldrich, unless indicated otherwise.
Animals
Male Wistar rats weighing 220 to 250 g were used. The animals were kept at a constant room temperature of 23-C with a 12-hour light-dark cycle and were allowed free access to water and standard laboratory chow (Biofarm, Zagyvaszántó, Hungary). In each experimental group, 5 to 8 rats were used. The experiments performed in this study were approved by the Animal Care Committee of the University.
Experimental Protocol
Rats were pretreated with 15 mg/kg AIHA (dissolved in 6 M HCl and pH set to 7.4 with NaOH in phosphate-buffered saline) or its vehicle IP 1 hour before injection with physiological saline or 3.5 g/kg L-arginineYHCl (350 mg/mL, pH: 7.4) IP. Rats were killed by exsanguination through the abdominal aorta after anesthetization with 44 mg/kg pentobarbital IP 24 hours after the L-arginine or physiological saline injection. The pancreas was quickly removed, cleaned from fat and lymph nodes, weighed, and frozen in liquid nitrogen and stored at j80-C until use. Furthermore, liver, kidney, and lung tissue were frozen from control animals for determination of arginase
Serum and Pancreatic Amylase Activity
The serum and pancreatic activities of amylase were determined by a colorimetric kinetic method (Dialab, Vienna, Austria).
Pancreatic Trypsin Activity
Pancreas samples were pulverized under liquid N 2 using a mortar and pestle. Pulverized tissue was suspended in icecold MOPS (3-[N-morpholino]propanesulfonic acid) buffer (5 mM MOPS, pH 6.5, 250 mM sucrose, 1 mM MgSO 4 ). The resulting homogenate was centrifuged (50 g for 5 minutes), and the supernatant was used for the enzyme assay. Trypsin activity was measured in Tris buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1 mM CaCl 2 ) by using the colorimetric substrate N-CBZ-Gly-Pro-Arg-p-nitroanilide (0.1 mM final concentration; Bachem GmbH, Weil am Rhein, Germany). Three-minute time courses of p-nitroaniline release were followed at 405 nm at room temperature with a Hitachi U-2900 spectrophotometer
AQ2
. Trypsin activity in the homogenate was estimated using a standard curve for purified bovine trypsin.
Arginase Activity
Parts of the liver, pancreas, kidney, and lung were homogenized in 9-fold excess (wt/vol) of ice-cold buffer containing 50 mM Tris-HCl (pH 7.5) supplemented with 1 mM phenyl methyl sulfonyl fluoride, 4 mM benzamidine, and 100 U/mL aprotinin using an Ultra-Turrax homogenizer AQ3 for 2 Â 30 seconds. The homogenates were then centrifuged at 25,000 g for 30 minutes (at 4-C), and the heat-activated (60-C, 20 minutes) supernatants (their protein concentrations were measured by the method of Bradford 14 ) were used for determination of arginase activity. Arginase activity was measured by exogenously added L-arginine using a colorimetric method, based on the determination of released urea. 9 Briefly, 20 mM L-arginineYHCl substrate (pH set to 9.7), 0.2 mM MnCl 2 , and the sample were mixed in 250 KL and incubated at 37-C for 5 to 15 minutes. The reaction was stopped by adding 250 KL 1 N HClO 4 and centrifuged, and 140 KL supernatant was used for urea determination by adding 1.36 mL diacetylmonoximethiosemicarbazide reagent after centrifugation; an aliquot was tested for released urea according to Coulombe and Favreau. 10 After heating at 100-C (20 minutes) and cooling, optical densities were read at 535 nm using urea standards.
The inhibitory effect of 0 to 120 KM AIHA on arginase activity was tested on rat liver homogenate and purified bovine liver arginase (Serva
AQ4
). Considering that the total water content of the rat is about 80%, 60 KM AIHA is equimolar to an in vivo dose of 15 mg/kg.
Pancreatic Myeloperoxidase Activity
Pancreatic myeloperoxidase (MPO) activity, as a marker of tissue leukocyte infiltration, was assessed using the method of Kuebler et al.
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Pancreatic Nonprotein Sulfhydryl Group Content and the Activities of Glutathione Peroxidase and Superoxide Dismutase
To determine nonprotein sulfhydryl group (NSG) content and activities of glutathione peroxidase (GSH-Px), MnY and Cu/ZnY superoxide dismutase (SOD), a part of the pancreas was homogenized, the homogenates centrifuged at 3000 g for 10 minutes, and the supernatants were used for measurements as described previously. 12 
Expression of Pancreatic Heat Shock Proteins 27 and 72
Heat shock proteins (HSPs) are stress-inducible chaperones. Western blot analysis of pancreatic HSP27 and HSP72 expression was performed from the cytosolic fraction of the pancreas homogenate. Pancreatic cytosolic fractions were prepared as described previously. 13 The protein concentration of the homogenate was determined by the method of Bradford.
14 Forty micrograms of protein was loaded per lane. Samples were electrophoresed on a 10% sodium dodecyl sulfateYpolyacrylamide gel according to the method of Laemmli. 15 The proteins on the gels were either stained with Coomassie brilliant blue (to demonstrate equal loading of proteins for Western blot analysis) or transferred to a nitrocellulose membrane for 1 hour at 100 V. Equal transfer of proteins was verified by ponceau S staining. Membranes were blocked in 5% nonfat dry milk (Bio-Rad
AQ5
) for 1 hour and incubated with rabbit anti-HSP72 (1:10,000 dilution, characterized previously by Kurucz et al, 16 ) or goat anti-HSP27 (1:500 dilution; Santa Cruz Biotechnology, Santa Cruz, Calif ) antibody for an additional 1 or 3 hours (respectively) at room temperature. The 
Histological Examination
A portion of the pancreas was fixed in 6% neutral formaldehyde solution and subsequently embedded in paraffin. Sections were cut at 4-Km thickness and stained with hematoxylin and eosin. The slides were coded and read by 2 independent observers who were blind to the experimental protocol. Pancreatic tissue injury was evaluated as described previously. 7 Briefly, semiquantitative grading of interstitial edema (0Y3), vascular congestion (0Y1), leukocyte adhesion (0Y3) and infiltration (0Y4), and apoptosis (0Y3) and necrosis (0Y4) of acinar cells was determined in each animal.
Statistical Analysis
Results are expressed as means T SEM. Experiments were evaluated by using the analysis of variance followed by Dunnett multiple-comparisons post hoc test. Values of P G 0.05 were considered as significant.
RESULTS
Arginase Activity in the Liver, Pancreas, Lung, and Kidney
Arginase activity was by far the highest in the liver ( F2 Fig. 2) . Nevertheless, we could also detect arginase activity in the pancreas, lung, and kidney.
Effect of AIHA on Arginase Activity (+)-S-2-amino-6-iodoacetamidohexanoic acid dosedependently inhibited liver arginase activity of rat liver homogenate and purified bovine arginase in vitro ( Pretreatment with AIHA significantly ameliorated this increase of PW/BW ratio. Serum amylase activity was not significantly altered in any of the groups (Fig. 4B) . Pancreatic contents of amylase were significantly decreased in the L-arginineYtreated groups (Fig. 4C) . Pretreatment with AIHA did not influence pancreatic amylase activity in rats injected with L-arginine. Pancreatic trypsin activity was significantly increased by L-arginine administration (Fig. 4D) . Pretreatment with AIHA significantly ameliorated this increased pancreatic trypsin activity.
Pancreatic MPO Activity
Pancreatic MPO activity was significantly increased at 24 hours after L-arginine injection (Fig. 4E) . Pretreatment with AIHA significantly decreased MPO activity in the L-arginineY induced pancreatitis group.
Pancreatic Nonprotein Sulfhydryl Group Content and the Activities of GSH-Px and SOD
Pancreatic NSG content and GSH-Px activity were significantly increased 24 hours after the injection with L-arginine ( Arginase activity in the liver, pancreas, lung, and kidney of rats. Tissues were removed from control animals and then homogenized. Arginase activity was measured by exogenously added L-arginine using a colorimetric method, based on the determination of released urea. 
Histological Examination
The administration of 3.5 g/kg L-arginine caused severe necrotizing pancreatitis ( Table 1 ). Injection of AIHA in itself resulted in pancreatic hyperemia and mild inflammatory cell infiltration. However, AIHA pretreatment significantly reduced pancreatic damage in L-arginineYinduced pancreatitis.
DISCUSSION
We have previously demonstrated that IP injection of 3.5 g/kg L-arginine results in much greater increases in serum ornithine versus citrulline concentration. 7 This finding suggested a major role for arginase (rather than NOS) in the catabolism of L-arginine. In the present study, we have shown that pretreatment Arginase is a key enzyme of the hepatic urea cycle, so it was not surprising that the highest enzyme activity was found in the liver of rats. In accordance with values reported elsewhere, 17 arginase activity was several-order magnitudes higher in the liver compared with other tissues (pancreas, lung, and kidney). Therefore, most likely, large doses of L-arginine are metabolized mainly by the liver. In fact, serum L-arginine concentration was significantly reduced below the control value 24 hours after injection. 8 Two studies have investigated the changes in serum arginase activity in patients with acute pancreatitis. Serum arginase activity was unaltered in the early phases of acute pancreatitis. 18 On the contrary, Scibior et al 19 have found that serum arginase activity was significantly reduced by treatment of the disease.
(+)-S-2-amino-6-iodoacetamidohexanoic acid is an irreversible inhibitor of the ornithine decarboxylase and arginase and has been reported to have antifertility and antitumor effects. 20, 21 The dosing of AIHA was based on literature data. 20, 21 Sixty micromolars of AIHA (which corresponds to an in vivo dose of 15 mg/kg) inhibited arginase activity by about 25%. Although this rate of arginase inhibition is not great, even Table 1 . applying 120 KM AIHA in vitro did not result in significantly lower levels of arginase activity versus 60 KM (Fig. 3) . Furthermore, because arginase is a critical enzyme of the urea cycle, most likely we have a limit to what we could decrease enzyme activity without seeing any detrimental effects. Because AIHA also inhibits ornithine decarboxylase and ornithine per se can induce acute pancreatitis, the action of AIHA in modifying the acute pancreatitis response to arginine might be due to the inhibition of the latter step, which is the formation of precursor for polyamine synthesis. Interestingly, administration of AIHA in itself caused a stress response in the pancreas characterized by increased expression of HSP27 and HSP72. This may be due to the fact that inhibition of arginase activity will interfere with the urea cycle and increase levels of toxic ammonia. Preinduction of HSPs has been shown to protect against L-arginineYinduced acute pancreatitis, 22 although in our studies we found only reductions in proinflammatory cytokine synthesis. 23 Nevertheless, given these contrasting results, we cannot exclude the beneficial effect of these chaperones on disease progression, providing their levels are increased before the initiation of arginine pancreatitis. 24 The administration of AIHA 1 hour before L-arginine injection ameliorated the degree of pancreatic edema, but it did not influence serum amylase activity in L-arginineYinduced pancreatitis. Serum amylase activity is not a good marker of disease severity in this pancreatitis model; it is usually only mildly increased in the early phases of the disease. However, AIHA pretreatment also significantly reduced parameters of pancreatic oxidative stress, trypsin and MPO activity, and histological damage.
Taken together, our results suggest that AIHA pretreatment reduces the severity of L-arginineYinduced acute pancreatitis most likely by inhibiting arginase activity. Conversion of L-arginine to L-ornithine by arginase seems to be detrimental in L-arginineYinduced acute pancreatitis. Further studies are needed to determine how these basic amino acids produce pancreatic injury. 
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